PRT 062070 (Cerdulatinib)
目录号: A14147
Dual Syk and JAK 抑制剂
PRT062070 是一种新型口服双重脾脏酪氨酸激酶(Syk)和 janus kinase (JAK) 抑制剂。Cerdulatinib 优先抑制 JAK1 和 JAK3 依赖的细胞因子介导的信号传导和各种细胞类型的功能反应。
Discription | PRT062070 is a novel, oral, dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Cerdulatinib preferentially inhibited JAK1 and JAK3 dependent cytokine mediated signaling and functional responses in various cell types. | ||
---|---|---|---|
Targets |
|
目录号 | A14147 |
---|---|
分子式 | C20H27N7O3S |
分子量 | 445.54 |
CAS号 | 1198300-79-6 |
SMILES | CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N |
其他名称 | Cerdulatinib,PRT2070,PRT-2070,PRT 2070,PRT-062070,PRT062070 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2